To investigate the effects of RBMS1 on cardiac hypertrophy, we conducted a targeted overexpression study using adeno-associated virus 9 (AAV9) driven by the cardiomyocyte-specific troponin T2 (cTnT) promoter. This evidence concerns the gene TNNT2 and cardiac hypertrophy.